Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPELD: Xenon for Post-operative Delirium in Hip Fracture
NCT01199276Phase 2Completed
- Sponsor
- Air Liquide
- Start
- Sep 2010
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of xenon in postoperative delirium (POD), sponsored by Air Liquide. Started Sep 2010; status: completed.
02
Drugs
xenon
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT01199276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01199276.